Research Roundup


Debbie Rigby rounds up the latest in research news First-line treatment of osteoporosis with osteoanabolic therapy Osteoanabolic drugs, which form new bone and restore bone microarchitecture, are recommended as first-line treatment for osteoporosis patients at very high or imminent fracture risk, with sequential therapy involving antiresorptives providing optimal long-term outcomes. This article discusses the evidence

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Shift in thinking needed for asthma
Next Mind the gap: how pharmacists can help in the new aged care system